Revolver Therapeutics
Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.
$763.3K Pre Seed ·
Source: University of Bath
Funding history ↓Signals
Website registeredJun 2, 2025 (18 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Pre Seed | $763.3K | — | University of Bath |
Timeline
- Website created
Founders and team
JM
Jody Mason Founder & CSOLinkedIn · source: revolvertherapeutics.com
Companies like Revolver Therapeutics
OOna Therapeutics$86.6M Series B+ · Oct 2026
CCrossbow Therapeutics$77M Series B+ · Mar 2026
CCatch BioSeed · Mar 2026
220n BioSeed · May 2026
TTippingPoint Biosciences$4.5M Seed · Mar 2026
CCartography Biosciences$67M Series B+ · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/revolver-therapeutics (get a free API key).